Search

everythinglearnresearchcommunity

for

Search:↓

Women with lichen planopilaris and frontal fibrosing alopecia often have other health issues like hypothyroidism and lupus.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Diphenylcyclopropenone treatment helps prevent hair loss relapse in alopecia areata patients.

Early treatment of fibrosing alopecia in a pattern distribution may improve outcomes.

Adding antihistamines to topical corticosteroid and cryotherapy may improve hair regrowth in alopecia areata patients.

Low alternating doses of sodium divalproate reduced migraine frequency but caused weight gain.

PRP treatment increased hair density, especially in men and younger patients with AGA.

Low-dose naltrexone helps improve symptoms and stabilize frontal fibrosing alopecia and lichen planopilaris.

Degenerative changes in the lower cervical spine are common in patients with abnormal scalp sensations, with some improvement seen using pain medication and physical therapy.

Higher doses of spironolactone may improve acne in PCOS patients, but side effects are a concern.

Lichen planopilaris in men often involves scalp redness and itching, with some also having hair loss, mucosal lichen planus, or thyroid disease, and treatment improved symptoms in nearly half of the cases.

Hypothyroidism patients with hair loss typically have thinning hair, smaller hair follicles, and normal hair shedding.

Tofacitinib effectively regrows hair in alopecia areata patients, especially in younger individuals, with manageable side effects.

Lupus erythematosus can mimic alopecia areata, and trichoscopy is key for accurate diagnosis and better patient outcomes.

More severe hair loss is linked to more sexual dysfunction in both men and women.

Early treatment with JAK inhibitors leads to better hair regrowth in acute alopecia areata.

Premature graying of hair is more common in males and linked to family history, smoking, hair plucking, and low levels of certain vitamins and minerals.

Early hair loss may indicate a higher risk of diabetes in young and middle-aged adults.

Low-dose oral minoxidil is safe for hair loss, with no link between side effects and patient demographics.

Fibrosing alopecia can be stabilized or improved with anti-inflammatory treatments and hair growth agents.

CCCA mainly affects Black women and is linked to high-tension hairstyles, heating tools, chemical relaxants, and genetics.

Azathioprine is a safe and effective long-term treatment for severe alopecia areata, significantly improving hair regrowth.

Baricitinib effectively promotes hair regrowth in alopecia areata patients with mild side effects.

Androgenetic alopecia is linked to a higher risk of varicose veins, especially in men, but not to major vascular diseases.

Many patients with hair loss had low iron and vitamin D levels, but thyroid issues were not common.

Testosterone can help premenopausal and postmenopausal women with low sexual desire, but its long-term safety is unclear and it's not widely approved for this use.

Researchers developed a cost-effective 66 K SNP chip for cashmere goats that is accurate and useful for genetic studies.

Tofacitinib may help treat severe hair loss, but more research is needed.

People who get alopecia areata after age 50 usually have mild symptoms, high chances of hair regrowth, and often have other health conditions.

Patients with Lichen Planopilaris are more likely to have rosacea and skin cancer but less likely to have congestive heart failure, stroke, and glaucoma.